Description

3-(3-(4-(2-Fluorophenyl)Piperazin-1-Yl)-3-Oxopropyl)Benzo[D]Oxazol-2(3H)-One is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure incorporating a benzoxazolone and a fluorophenylpiperazine moiety. This compound is of significant value in medicinal chemistry research and development, serving as a critical building block for the synthesis of novel bioactive molecules. It is primarily sought after by R&D laboratories and pharmaceutical manufacturers engaged in developing central nervous system (CNS) agents and other therapeutic candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of potential drug candidates targeting neurological and psychiatric disorders.
• Medicinal Chemistry Research: Used as a scaffold or building block in structure-activity relationship (SAR) studies and hit-to-lead optimization.
• CNS Drug Development: Particularly relevant for the research of ligands interacting with serotonin, dopamine, or other neurotransmitter receptors due to its piperazine pharmacophore.
• Reference Standard: Serves as an analytical standard for quality control and method development in API manufacturing.
• Biochemical Tool Compound: Utilized in vitro and in vivo studies to investigate specific biological pathways and mechanisms.
• Custom Synthesis: A starting material for the contract synthesis of more complex, proprietary molecules for clinical trials.

Basic Information

Product Name	3-(3-(4-(2-Fluorophenyl)Piperazin-1-Yl)-3-Oxopropyl)Benzo[D]Oxazol-2(3H)-One
CAS No.	851988-78-8
Molecular Formula	C20H20FN3O3
Molecular Weight	369.39 g/mol
Synonyms	2(3H)-Benzoxazolone, 3-[3-[4-(2-fluorophenyl)-1-piperazinyl]-3-oxopropyl]-; 3-(3-(4-(2-Fluorophenyl)piperazin-1-yl)-3-oxopropyl)-1,3-benzoxazol-2-one; 3-[3-[4-(2-Fluorophenyl)piperazin-1-yl]-3-oxopropyl]-1,3-benzoxazol-2-one; 851988-78-8; AKOS005258030; BDBM50375666; FT-0697923; NS00023827; SCHEMBL15446869
EINECS	Contact for details

Quality Control

Our 3-(3-(4-(2-Fluorophenyl)Piperazin-1-Yl)-3-Oxopropyl)Benzo[D]Oxazol-2(3H)-One is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.